- Home
- LYEL vs RDVT Comparison
LYEL vs RDVT Comparison
Compare LYEL & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYEL | RDVT |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 527.9M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LYEL | RDVT |
|---|---|---|
| Price | $23.86 | $38.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $30.60 | ★ $62.00 |
| AVG Volume (30 Days) | 76.6K | ★ 100.2K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.00 |
| EPS | N/A | ★ 0.91 |
| Revenue | $36,000.00 | ★ $90,252,000.00 |
| Revenue This Year | N/A | $16.31 |
| Revenue Next Year | $16,285.34 | $13.83 |
| P/E Ratio | ★ N/A | $40.54 |
| Revenue Growth | N/A | ★ 20.03 |
| 52 Week Low | $0.39 | $33.40 |
| 52 Week High | $45.00 | $64.14 |
Technical Indicators
Market Signals| Indicator | LYEL | RDVT |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 52.39 |
| Support Level | $21.27 | $35.84 |
| Resistance Level | $27.30 | $39.63 |
| Average True Range (ATR) | 1.70 | 1.90 |
| MACD | 0.50 | 0.46 |
| Stochastic Oscillator | 80.58 | 88.12 |
Price Performance
Historical ComparisonAbout LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About RDVT Red Violet Inc.
Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.